Patents by Inventor Walter Pickett

Walter Pickett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for screening and identifying compounds
    Publication number: 20060068456
    Abstract: The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
    Type: Application
    Filed: November 2, 2005
    Publication date: March 30, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: James Landro, David Osterman, Walter Pickett
  • Method for assaying enzyme activity
    Patent number: 6994956
    Abstract: The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: February 7, 2006
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: James A. Landro, David G. Osterman, Walter Pickett
  • Methods for screening and identifying compounds
    Publication number: 20050064531
    Abstract: The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
    Type: Application
    Filed: August 4, 2004
    Publication date: March 24, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: James Landro, David Osterman, Walter Pickett